Furthermore, in a model of HHT caused by loss of BMP9 and BMP10 ligands, endothelial mTOR levels are increased and targeting mTOR reduces vascular defects (Ruiz et al., 2020). The gene discussed is BMP10; the disease is hereditary hemorrhagic telangiectasia.